[{"status": "Terminated", "city": "Trujillo Alto", "state": "PR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91325", "recalling_firm": "Frenda Corporation", "address_1": "Calle A Lote 7 Parque Ind Las Cuevas", "address_2": "N/A", "postal_code": "00976", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Puerto Rico", "recall_number": "D-0255-2023", "product_description": "Easy Clean Alcohol Mult Surface Disinfecting Cleaner 75% Ethyl Alcohol, 32 FL. OZ. (946 mL.), Manufactured by: Frenda Corporation Trujilio Alto, PR 00976, UPC 8 91857 00052 3", "product_quantity": "8475 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20221215", "center_classification_date": "20230130", "termination_date": "20240910", "report_date": "20230208", "code_info": "Lots: C012821, C021421, C022121"}, {"status": "Terminated", "city": "Iselin", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75655", "recalling_firm": "Nationwide Laboratories, LLC", "address_1": "33 Wood Ave S Ste 600", "address_2": "", "postal_code": "08830-2717", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in USA and Puerto Rico", "recall_number": "D-0168-2017", "product_description": "Phenazopyridine Hydrochloride Tablets, USP, 200 mg, 100 count bottles, Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey  08830, NDC 42937-702-10.", "product_quantity": "5,786,653 tablets", "reason_for_recall": "CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.", "recall_initiation_date": "20161028", "center_classification_date": "20161201", "termination_date": "20180517", "report_date": "20161207", "code_info": "Lot #: 28181501, 28181502, Exp 03/17; 28181503, 28181504, Exp 08/17; 28181505, 28181506, Exp 09/17; 28181601, Exp 01/18", "more_code_info": ""}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1159-2019", "product_description": "Heparin 10 mL/Marcain 0.25% 20 mL/Sodium Bicarbonate 8.4%-40 mL/per 70 mL, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "12 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"country": "United States", "city": "Salt Lake City", "address_1": "2401 S Foothill Dr", "reason_for_recall": "Lack of processing controls: Isomeric Pharmacy Solution, LLC is recalling Betamethasone Acetate / Betamethasone Sodium Phosphate 7 mg/mL INJ SUSP because of the potential of drug clumps in the vial of the sterile drug product and larger particle sizes.", "address_2": "", "product_quantity": "2,331 vials", "code_info": "Lot# 03037, Exp 8/17/16; 03042, 03043, Exp 8/31/16; 04043, Exp 9/29/16; 04047, 04048, Exp 10/1/16; 04052, 04053, Exp10/2/16; 05042, Exp 10/29/16; 05046, Exp 11/2/16; 05048, 05049, Exp 11/3/16; 05050 Exp 11/4/16", "center_classification_date": "20160804", "distribution_pattern": "Nationwide and Puerto Rico", "state": "UT", "product_description": "Betamethasone Acetate / Betamethasone Sodium Phosphate Injectable Suspension, 7 mg/ mL,10 mL Multi-Dose vial for injection, Rx Only, Isomeric Pharmacy Solution, 2401 Foothill Dr., Salt Lake City, UT 84109", "report_date": "20160810", "classification": "Class II", "openfda": {}, "recalling_firm": "Isomeric Pharmacy Solution, LLC", "recall_number": "D-1454-2016", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "74832", "termination_date": "20170801", "more_code_info": "", "recall_initiation_date": "20160801", "postal_code": "84109-1479", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Albuquerque", "state": "NM", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86123", "recalling_firm": "Calvin Scott & Company, Inc.", "address_1": "209 Eubank Blvd Ne", "address_2": "N/A", "postal_code": "87123-2745", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1528-2020", "product_description": "Phentermine HCL Blue/Clear capsules, 30mg, packaged in a) 10-count bags (NDC 10702-0028-10), b) 28-count bags (NDC 10702-0028-10) and c) 56-count bags (NDC 10702-0028-10), Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, Manufactured by KVK-Tech Newtown, PA 18940; NDC 10702-0028-10", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.", "recall_initiation_date": "20200727", "center_classification_date": "20200820", "termination_date": "20240411", "report_date": "20200826", "code_info": "Lot #:  a)19290, Exp. Date: 10/20;  b) 19224; Exp. Date: 08/20;  19249, Exp. Date: 09/20; 19290, Exp. Date: 10/20;  19322, Exp. Date: 12/20; 20013, Exp. Date: 01/21; 20039, Exp. Date: 02/21  c) 19290, Exp. Date: 10/20"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0218-2015", "product_description": "PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN, 17.64mg/0.58mg/5.8mcg, injectable, 1.7 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "1.7 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140828@4/1.7, discard date: 10/15/2014"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202557"], "brand_name": ["BUSPIRONE HYDROCHLORIDE"], "generic_name": ["BUSPIRONE HYDROCHLORIDE"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-200", "16729-203", "16729-289", "16729-201", "16729-202"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUSPIRONE HYDROCHLORIDE"], "rxcui": ["866018", "866083", "866090", "866094", "866111"], "spl_id": ["4092e48b-b3d6-abf3-e063-6394a90afe61"], "spl_set_id": ["3da22999-f5fb-49fd-acde-c3006598e985"], "package_ndc": ["16729-203-12", "16729-203-01", "16729-203-59", "16729-203-16", "16729-203-17", "16729-289-12", "16729-289-01", "16729-289-59", "16729-289-16", "16729-289-17", "16729-200-01", "16729-200-16", "16729-200-17", "16729-201-01", "16729-201-16", "16729-201-17", "16729-202-01", "16729-202-16", "16729-202-17"], "is_original_packager": [true], "upc": ["0316729289016", "316729289122"], "unii": ["207LT9J9OC"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0379-2023", "product_description": "BusPIRone Hydrochloride Tablets USP 30 mg, 60-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA, NDC 16729-289-12 UPC 3 16729 28912 2", "product_quantity": "25,812 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: P2105551, Exp. Date 7/31/2024;", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: MINOCYCLINE HCL, Capsule, 100 mg may have potentially been mislabeled as the following drug:  PROGESTERONE, Capsule, 100 mg, NDC 00591396401, Pedigree: AD73611_4, EXP: 5/30/2014.", "address_2": "", "product_quantity": "50 Capsules", "code_info": "MINOCYCLINE HCL, Capsule, 100 mg has the following codes:   Pedigree:  AD73611_10, EXP: 5/30/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MINOCYCLINE HCL, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591569550.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-979-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0478-2019", "product_description": "Dexpanthenol, 250mg/mL Injection, 10ml vial,  Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684", "product_quantity": "7 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lot: 11052018@5 BUD: 12/20/2018"}, {"status": "Terminated", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81603", "recalling_firm": "AVKARE Inc.", "address_1": "615 N 1st St", "address_2": "N/A", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "WA only", "recall_number": "D-0285-2019", "product_description": "Germ Bloc Health Hand Sanitizer Foam (benzalkonium chloride 0.13%) 7.5fl.oz./222mL refill bags, AvKARE, Inc. Pulaski, TN 38478 www.avkare.com, NDC 5026835427, UPC 3 50268 35408", "product_quantity": "1602 bags", "reason_for_recall": "Microbial Contamination of Non-Sterile Product: Presence of Pseudomonas aeruginosa in product", "recall_initiation_date": "20181120", "center_classification_date": "20181128", "termination_date": "20200507", "report_date": "20181205", "code_info": "Lot #: 13417 Exp. 05/2020"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Pyridoxine (p-f) 100mg/ml", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1129-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1003-2022", "product_description": "Dexmedetomidine HCL Single Dose Vial 200 mcg per 2 mL (100mcg/mL), Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-0209-02", "product_quantity": "5 cartons/2 ml single dose vials", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Bellflower", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72361", "recalling_firm": "Pacific Healthcare, Inc dba B&B Pharmacy", "address_1": "10244 Rosecrans Ave", "address_2": "N/A", "postal_code": "90706-2602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA and NJ", "recall_number": "D-0174-2016", "product_description": "PAPA/PGE1/PHENTO (30mg/10mg/1mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA", "product_quantity": "1-5 ml vial; 3-10 ml vials", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "recall_initiation_date": "20151007", "center_classification_date": "20151110", "termination_date": "20160407", "report_date": "20151118", "code_info": "5 ml --- 07062015@2, exp 1/2/2016    10 ml --- 06042015@4, exp 12/1/2015; 06052015@15, exp 12/2/2015; 07132015@3, exp 1/9/2016"}, {"status": "Terminated", "city": "Concord", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "75215", "recalling_firm": "Mckesson Packaging Services", "address_1": "7101 Weddington Rd NW", "address_2": "N/A", "postal_code": "28027-3412", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CO, IL, LA, OH", "recall_number": "D-1527-2016", "product_description": "Xanax (Alprazolam) USP, CIV, 0.5 mg tablets , 10 x 10 blister cards per carton, Rx Only, Manufactured by Sandoz  Inc., Princeton, NJ 08805, NDC  63739-669-10", "product_quantity": "3,492 unit cartons of 10 x 10 blister cards", "reason_for_recall": "Labeling: Missing Label-Primary packaging label (i.e. blister card) is blank and contains no product information (e.g. product name, strength, lot number, expiry).", "recall_initiation_date": "20160915", "center_classification_date": "20160927", "termination_date": "20170503", "report_date": "20161005", "code_info": "Lot #: 0111512; Exp. 08/17"}, {"status": "Terminated", "city": "Lawrence", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90398", "recalling_firm": "Plastikon Healthcare LLC", "address_1": "3780 Greenway Cir", "address_2": "N/A", "postal_code": "66046-5440", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1489-2022", "product_description": "Diphenhydramine HCl Oral Solution, 25 mg / 10 mL, 10 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Major Pharmaceuticals, 17177 N Laurel Park Dr. Suite 233, Livonia, MI 48152, NDC 0904-6741-72", "product_quantity": "349,100 cups", "reason_for_recall": "CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.", "recall_initiation_date": "20220607", "center_classification_date": "20220906", "termination_date": "20250625", "report_date": "20220914", "code_info": "Lot # 20065A, EXP Jun. 2022; 20068A, 20070A, EXP Jul. 2022; 20097A, 20098A, EXP Oct. 2022; 21055A, EXP May. 2023; 21083A, EXP Jul. 2023; 21091A, EXP Aug. 2023; 21112A, EXP Oct. 2023"}, {"status": "Terminated", "city": "Texarkana", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81061", "recalling_firm": "Humco Holding Group, Inc", "address_1": "7400 Alumax Rd", "address_2": "N/A", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0023-2019", "product_description": "Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain Liothyronine 9.7 mcg/grain Active Pharmaceutical Ingredient Rx Only 100 grams NDC 0395-8077-62 Packaged by: Humco Texarkana, TX 75501 USA", "product_quantity": "Unknown.", "reason_for_recall": "CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.", "recall_initiation_date": "20180828", "center_classification_date": "20181012", "termination_date": "20200507", "report_date": "20181024", "code_info": "Lots: A24543 Exp. 02/2019; A25724 Exp. 01/2019; A25529 Exp. 04/2019; A25723 Exp. 04/2019; A27120 Exp. 05/2019; A27811 Exp. 06/2019; A28626 Exp. 06/2019; A29171 Exp. 06/2019; A29221 Exp. 06/2019"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #'s: 0391287, 0398843, 0398843", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "AFLIBERCEPT, SDPF - (0.05ML SYRINGE, 31G, 5/16\") 40MG/ML INJECTABLE 0.35 ML, 0.95 ML, 1.25 ML (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1451-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Greer", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75415", "recalling_firm": "North American Rescue LLC.", "address_1": "35 Tedwall Ct", "address_2": "N/A", "postal_code": "29650-4791", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Australia & Switzerland", "recall_number": "D-0175-2017", "product_description": "Range Trauma Kit Hardcase - Product Code 85-0889,  North American Rescue", "product_quantity": "unknown", "reason_for_recall": "Lack of Assurance of Sterility: Concerns with product sterility by the manufacturer of the eye wash irrigating solution.", "recall_initiation_date": "20160927", "center_classification_date": "20161208", "termination_date": "20170309", "report_date": "20161214", "code_info": "Kit Part # 85-0889 - Kit Lot # 85-0889082416, 85-0889071816, 85-0889071916, 85-0889071416, 85-0889052316, 85-0889050416, 85-0889042016, 85-0889041416, 85-0889090616, 85-0889090716, 85-0889060216, 85-0889062216, 85-0889080116, 85-0889080816"}, {"status": "Terminated", "city": "Waukon", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80963", "recalling_firm": "Beaumont Bio-med, Inc.", "address_1": "21 1st Ave NE", "address_2": "N/A", "postal_code": "52172-1705", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1192-2018", "product_description": "Skin Irritation & Itch Response Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber glass oral spray bottle, Distributed by Beaumont Bio-Med, Inc., Waukon, IA 52172; NDC 58066-7002-7", "product_quantity": "192 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20180831", "center_classification_date": "20180917", "termination_date": "20220916", "report_date": "20180926", "code_info": "Lot: 091515C, Exp 09/2018; 050118S, Exp 05/2021"}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA088487"], "brand_name": ["HYDROXYZINE PAMOATE"], "generic_name": ["HYDROXYZINE PAMOATE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-0302", "0555-0323", "0555-0324"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROXYZINE PAMOATE"], "rxcui": ["995232", "995253", "995278"], "spl_id": ["c307ca43-d41f-401b-bd15-0c753eca86e5"], "spl_set_id": ["06068fff-2e79-4721-bcc7-b0938aa20e7a"], "package_ndc": ["0555-0323-02", "0555-0323-04", "0555-0302-02", "0555-0302-04", "0555-0324-02"], "is_original_packager": [true], "upc": ["0305550302025", "0305550323020"], "unii": ["M20215MUFR"]}, "product_type": "Drugs", "event_id": "67412", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "425 Privet Rd", "address_2": "", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1093-2014", "product_description": "Teva Hydroxyzine Pamoate Capsules, USP, 100 mg, 100- count bottle,Rx only, Distributed by Teva Pharmaceuticals USA, Sellersville, PA. NDC 0555-0324-02", "product_quantity": "2494 capsules", "reason_for_recall": "CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 100 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.", "recall_initiation_date": "20140124", "center_classification_date": "20140228", "termination_date": "20141008", "report_date": "20140312", "code_info": "Lot #  34017426A, Exp. 10/16.", "more_code_info": ""}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Ste 100", "reason_for_recall": "Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules", "address_2": "", "product_quantity": "", "code_info": "Lots: 10029201 Exp. 11/17/2019,    10029983 Exp. 11/22/2019,    10029987 Exp. 11/22/2019,    10030428 Exp. 11/26/2019,    10030879 Exp. 11/28/2019,    10031240 Exp. 12/10/2019,  10031241 Exp. 12/10/2019,  10031344 Exp. 12/12/2019,    10031343 Exp. 12/12/2019,    10031394 Exp. 12/12/2019,    10031612 Exp. 12/19/2019,    10031665 Exp. 12/20/2019,  10031666 Exp. 12/20/2019,    10031590 Exp. 12/18/2019,    10031787 Exp. 12/23/2019,    10032036 Exp. 12/27/2019,    10032305 Exp. 12/31/2019,    10032444 Exp. 1/2/2020,    10033172 Exp. 1/12/2020", "center_classification_date": "20191203", "distribution_pattern": "Nationwide.", "state": "TX", "product_description": "fentaNYL 2000 mcg/100 mL (20 mcg/mL) in 0.9% Sodium Chloride, 100 mL Bag, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478  NDC 70092-1094-36", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "QuVa Pharma, Inc.", "recall_number": "D-0563-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84263", "termination_date": "20200605", "more_code_info": "", "recall_initiation_date": "20191112", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-075-2014", "product_description": "Dexamethasone 8mg 10ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "17 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-832-2015", "product_description": "Paromomycin Sulphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "25 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Completed", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92917", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed nationwide to 100 consignees. Please refer to consignee list.", "recall_number": "D-1168-2023", "product_description": "BD ChloraPrep Clear, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Sterile Solution, 0.03mL (1 ml) each, 60 applicators in carton, applicator is sterile if package is intact. CareFusion 213, LLC, El Paso, TX 79912, subsidiary of Becton, Dickinson and Co., NDC 54365-400-31 REF 930480  Product is packaged in the following manner: There is one (1) sterile applicator (sponge) per pouch. Each inner carton contains sixty (60) pouches. There are four (4) inner cartons per shipping case (total of 240 pouches per case).", "product_quantity": "398,160 cartons", "reason_for_recall": "Stability data does not support expiry: Shelf-life of the impacted lots of BD ChloraPrep\" Clear 1 mL Applicator cannot be substantiated beyond 12-months although labeled with 36-month expiry. Stability studies indicate that the impacted lots, if stored at 30\u00bfC/75% relative humidity continuously beyond 12 months, may exhibit growth of Aspergillus penicillioides.", "recall_initiation_date": "20230825", "center_classification_date": "20230915", "report_date": "20230927", "code_info": "Lot # 2272350, Exp. Date 09/30/2025 and Lot # 2301939, Exp. Date 09/30/2025", "more_code_info": ""}, {"status": "Completed", "city": "Bentonville", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90359", "recalling_firm": "Walmart Inc", "address_1": "702 Sw 8th St Ms 275", "address_2": "", "postal_code": "72716-6299", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1159-2022", "product_description": "Artri King Reforzado con Ortiga Omega 3 Tablets, ORIGINAL, a) 100-count bottles labeled with UPC 7 501031 111190 and UPC 6 09002 40885, and b) 2 pack of 100-count bottles per carton UPC 3 72426 01434", "product_quantity": "1308 bottles total", "reason_for_recall": "Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims.", "recall_initiation_date": "20220524", "center_classification_date": "20220624", "report_date": "20220622", "code_info": "All product lots.", "more_code_info": ""}, {"country": "United States", "city": "Oklahoma City", "address_1": "755 Research Pkwy Ste 150", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.", "address_2": "", "product_quantity": "unknown", "code_info": "all lot codes", "center_classification_date": "20140729", "distribution_pattern": "Nationwide", "state": "OK", "product_description": "Dermamedics Post Procedure Cream, 1 ounce containers which were distributed with a SKU number of DM 1026", "report_date": "20140806", "classification": "Class II", "openfda": {}, "recalling_firm": "Dermamedics, L.L.C.", "recall_number": "D-1487-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67247", "termination_date": "20170314", "more_code_info": "", "recall_initiation_date": "20140110", "postal_code": "73104-3621", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090034"], "brand_name": ["RIFAMPIN"], "generic_name": ["RIFAMPIN"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-658", "68180-659"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RIFAMPIN"], "rxcui": ["198201", "198202"], "spl_id": ["3c9f0101-dcf8-487e-985e-09c56746d3a1"], "spl_set_id": ["b56004f0-f23d-47f6-80c7-39884fccbccc"], "package_ndc": ["68180-658-06", "68180-658-01", "68180-659-06", "68180-659-07", "68180-659-01"], "is_original_packager": [true], "nui": ["N0000175500", "M0019113"], "pharm_class_epc": ["Rifamycin Antibacterial [EPC]"], "pharm_class_cs": ["Rifamycins [CS]"], "unii": ["VJT6J7R4TR"]}, "product_type": "Drugs", "event_id": "90616", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-1343-2022", "product_description": "Rifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, 21202  NDC: 68180-658-06", "product_quantity": "7,872/30 count bottles", "reason_for_recall": "CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity.", "recall_initiation_date": "20220728", "center_classification_date": "20220816", "termination_date": "20231005", "report_date": "20220824", "code_info": "Lot #A200170, exp. date December 2023", "more_code_info": ""}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "40 vials", "code_info": "Lot # t01-13-2017@84, Exp 4/18/2017; 02-02-2017@97, Exp 5/3/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "PROCAINE HCL *5ML* SDV SULFITE FREE 1% INJ, Injection, 1%, RXxonly, 5mL Glass/Single Dose vials, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0772-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Elizabeth", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73474", "recalling_firm": "Actavis Elizabeth LLC", "address_1": "200 Elmora Ave", "address_2": "N/A", "postal_code": "07202-1106", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US: Nationwide", "recall_number": "D-0813-2016", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets, 10 mg, 100 ct. bottle, Rx Only.  Manufactured by: Actavis Elizabeth LLC, Elmora Avenue, Elizabeth, NJ 07207. Distributed by: Actavis, Inc., 80 Columbia Road, Bldg B, Morristown, NJ 07960. NDC: 45963-745-11.", "product_quantity": "114,388 Bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification for impurities.", "recall_initiation_date": "20160216", "center_classification_date": "20160407", "termination_date": "20170922", "report_date": "20160413", "code_info": "Lot #: 2172#141, Expiry: 3/16; Lot #: 4217K141, Expiry: 3/16;  Lot #: 0420A151, Expiry: 7/16; Lot #: 0421A151, Expiry: 7/16; Lot #: 0854B151, Expiry: 10/16; Lot #: 1329C151, Expiry: 10/16; Lot #: 2692F151, Expiry; 2/17; Lot #: 3202G151, Expiry: 3/17; Lot #: 3796J151, Expiry: 3/17; Lot #: 3797J151, Expiry: 4/17.", "more_code_info": ""}, {"status": "Terminated", "city": "Aurora", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71535", "recalling_firm": "the Compounder", "address_1": "340 Marshall Ave Unit 100", "address_2": "N/A", "postal_code": "60506-5649", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0225-2016", "product_description": "ESTRIOL 5 ESTRADIOL (Estradiol (E2) Trit (Yellow)) 0.95 ESTRONE (Estrone E1) Trit (Red)) 0.02 TEST (Testosterone USP) 0.75MG/ML W/V (weight/volume)  transdermal cream, dispensed in 10 mL prefilled, amber syringes, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.", "product_quantity": "20 (10mL) syringes", "reason_for_recall": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.", "recall_initiation_date": "20150310", "center_classification_date": "20151110", "termination_date": "20160519", "report_date": "20151118", "code_info": "Lot # 12182014:10@21, Exp 6/16/2015; Lot # 01292015:64@13, Exp 7/28/2015"}, {"status": "Ongoing", "city": "Naples", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078466"], "brand_name": ["AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE"], "generic_name": ["AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-459", "68180-755", "68180-756", "68180-472", "68180-463", "68180-473", "68180-759", "68180-760", "68180-757", "68180-758"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "BENAZEPRIL HYDROCHLORIDE"], "rxcui": ["898342", "898346", "898350", "898353", "898356", "898359"], "spl_id": ["53566d4f-ff40-4815-b922-3416cde56fb1"], "spl_set_id": ["968c611b-43a7-40f0-9ed3-aa67ee88364b"], "package_ndc": ["68180-755-01", "68180-755-02", "68180-755-03", "68180-756-01", "68180-756-02", "68180-756-03", "68180-459-01", "68180-459-02", "68180-459-03", "68180-472-01", "68180-472-02", "68180-472-03", "68180-463-01", "68180-463-02", "68180-463-03", "68180-473-01", "68180-473-02", "68180-473-03", "68180-759-01", "68180-759-02", "68180-759-03", "68180-760-01", "68180-760-02", "68180-760-03", "68180-757-01", "68180-757-02", "68180-757-03", "68180-758-01", "68180-758-02", "68180-758-03"], "is_original_packager": [true], "upc": ["0368180459019"], "unii": ["N1SN99T69T", "864V2Q084H"]}, "product_type": "Drugs", "event_id": "97182", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "5801 Pelican Bay Blvd", "address_2": "Suite 500", "postal_code": "34108-2755", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0542-2025", "product_description": "Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg, 100 Capsules bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL, 34108, United States, Manufactured by: Lupin Limited, Goa 103 722, INDIA, NDC 68180-755-01.", "product_quantity": "7668 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: released with wrong expiry date as Feb.2027 instead of Jan.2027", "recall_initiation_date": "20250702", "center_classification_date": "20250728", "report_date": "20250806", "code_info": "Lot GB01616, expiration 2/28/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211082"], "brand_name": ["RANOLAZINE"], "generic_name": ["RANOLAZINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-319", "68462-320"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RANOLAZINE"], "rxcui": ["616749", "728231"], "spl_id": ["8872581f-53be-4bde-8d22-c6960f11e9d6"], "spl_set_id": ["0cf58732-c242-49b0-8e3f-248778b4458d"], "package_ndc": ["68462-319-60", "68462-319-05", "68462-320-60", "68462-320-05"], "is_original_packager": [true], "upc": ["0368462320600", "0368462319604"], "nui": ["N0000175427", "N0000190114", "N0000185503", "N0000182137", "N0000187061"], "pharm_class_epc": ["Anti-anginal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "unii": ["A6IEZ5M406"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0335-2025", "product_description": "Ranolazine  Extended-Release Tablets  1000mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-320-60", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17240040, exp. date Dec-25"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-076-2014", "product_description": "Dexamethasone LA 16mg, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "151 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Chatham", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71591", "recalling_firm": "Liberty Drug & Surgical", "address_1": "195 Main St", "address_2": "N/A", "postal_code": "07928-2405", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Physicians, Medical Facilities, and Prescription Specific Patients in NJ and NY", "recall_number": "D-1402-2015", "product_description": "Hydroxocobalamin (Preserved) 1,000 mcg/mL Injectable, 1 mL vial, Rx only, Liberty Drug Compound Center, 195 Main St., PO Box 267, Chatham, NJ  07928.", "product_quantity": "6 vials", "reason_for_recall": "Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.", "recall_initiation_date": "20150615", "center_classification_date": "20150827", "termination_date": "20180423", "report_date": "20150902", "code_info": "Lot #: 06102015@15, Exp 07/25/15"}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74187", "recalling_firm": "Well Care Compounding Pharmacy", "address_1": "3430 E Tropicana Ave Ste 9", "address_2": "N/A", "postal_code": "89121-7345", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "NV", "recall_number": "D-0986-2016", "product_description": "GLUTATHIONE 100MG/ML, packaged in 10 mL vials, Well Care Compounding Pharmacy Las Vegas, NV 89121", "product_quantity": "869 Units (Total All Products)", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.", "recall_initiation_date": "20160517", "center_classification_date": "20160609", "termination_date": "20170113", "report_date": "20160615", "code_info": "Lot #: 02222016:97@38, Exp.05/24/2016; Lot #: 03032016:27@26 , Exp. 06/26/2016; Lot #: 4272016:60@37, Exp. 07/26/2016; Lot #: 01132016:18@44, Exp. 02/03/2016; Lot #: 01132016:74 @17, Exp. 03/04/2016; Lot #: 01132016:90@9, Exp. 03/04/2016; Lot #: 02222016:34@23, Exp. 04/03/2016; Lot #: 04282016:79@45, Exp. 06/27/2016"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "70148", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-462-2015", "product_description": "Abington Memorial Hospital (PA) TPN Neonatal Starter 0.4-0.599 Kg, Amino Acids, Neonate 3g, Dextrose 5%, 150 ml, Additives: heparin PF 75 units, Calcium Gluconate 300mg, compound vol: 150 ml,  sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.", "product_quantity": "1 bag", "reason_for_recall": "Non-Sterility: Out of specification results for the sterility test for microbial contamination.", "recall_initiation_date": "20141217", "center_classification_date": "20150408", "termination_date": "20150819", "report_date": "20150415", "code_info": "lot number 37-74653, Made on 15 DEC 2014, EXP 24 DEC 2014, CAPS Rx: 37-74653-0-1-R, Disp ID: 37-1124735"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91980", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "RemedyRepack distributed product to consignees nationwide within the United States", "recall_number": "D-0496-2023", "product_description": "Simvastatin 10 mg tablets, packaged in a) 30-count bottles (NDC 70518-0064-01) and b) 90-count bottles (NDC 70518-0064-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701", "product_quantity": "a) 1,262 bottles, b) 95 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20230320", "center_classification_date": "20230331", "termination_date": "20231019", "report_date": "20230412", "code_info": "Lot #: a) J0675206-011223, J0669260-121922, Exp. Date 01/31/2024; J0656820-103122, J0647161-091722, Exp. Date 09/30/2023 Exp. Date 11/30/2023; J0621491-052722, Exp. Date 06/30/2023; J0638138-080822, Exp. Date 08/31/2023, J0610887-041122, Exp. Date 04/30/2023.  Lot # b) B1887315-100422, Exp. Date 02/28/2024; B1829906-083122, B1769715-071622, Exp. Date 09/30/2023; B1906605-101422, Exp. Date 02/28/2024; B1965118-111622, Exp. Date 02/28/2025.", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204937"], "brand_name": ["BUPRENORPHINE"], "generic_name": ["BUPRENORPHINE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-3239", "0093-3656", "0093-3657", "0093-3658", "0093-3659"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["BUPRENORPHINE"], "rxcui": ["904870", "904876", "904880", "1432969", "1542997"], "spl_id": ["192dd133-b93c-43a0-80be-550b6e771c4f"], "spl_set_id": ["36995ce3-b515-447b-baa9-aa14f84060d8"], "package_ndc": ["0093-3656-40", "0093-3239-40", "0093-3657-40", "0093-3658-40", "0093-3659-40", "0093-3656-21"], "is_original_packager": [true], "nui": ["N0000175689", "N0000175685"], "pharm_class_epc": ["Partial Opioid Agonist [EPC]"], "pharm_class_moa": ["Partial Opioid Agonists [MoA]"], "unii": ["40D3SCR4GZ"]}, "product_type": "Drugs", "event_id": "86379", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S. and PR", "recall_number": "D-0003-2021", "product_description": "Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only, Manufactured by: 3M Drug Delivery Systems, 19901 Nordhoff street, Northridge, CA 91324 USA, Manufactured for: Teva Pharmaceuticals USA Inc., North Wales, PA 19454, carton NDC: 0093-3656-40, patch NDC: 0093-3656-21.", "product_quantity": "32,543 cartons", "reason_for_recall": "Failed Stability Specifications: Below specification result for buprenorphine release rate.", "recall_initiation_date": "20200904", "center_classification_date": "20201001", "termination_date": "20210826", "report_date": "20201007", "code_info": "Lot # 190017, exp. 02/2021; 190161, exp. 08/2021"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85797", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States, including Puerto Rico.", "recall_number": "D-1331-2020", "product_description": "Metformin Hydrochloride Extended - Release Tablets, USP, 500 mg, a) 100 (NDC 62037-571-01) and b) 1,000 (NDC 62037-571-10) count bottles, Rx Only, Manufactured by: Watson Pharma Private Limited, Verna, Salcette Goa, Distributed by: Actavis Pharma, Inc., Parsippany, NJ", "product_quantity": "a) 92,793 bottles and b) 4,824 bottles", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200602", "center_classification_date": "20200619", "termination_date": "20240412", "report_date": "20200701", "code_info": "a)  1329548A, exp. date 06/2020  1338302M, exp. date  10/2020  1348968M, exp. date  10/2020  1348969M, exp. date  10/2020  1348970M, exp. date  11/2020  1376339M,, exp. date  09/2021  b)   1323460M, exp. date  06/2020  1330919M, exp. date  6/2020  1338300A, exp. date 10/2020  1341135M, exp. date  12/2020  1391828M, exp. date  11/2021"}, {"status": "Terminated", "city": "Torrance", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M009"], "brand_name": ["CVS MOTION SICKNESS FAST MELTING"], "generic_name": ["MECLIZINE HYDROCHLORIDE"], "manufacturer_name": ["CVS Pharmacy, Inc."], "product_ndc": ["59779-534"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MECLIZINE HYDROCHLORIDE"], "rxcui": ["1663815"], "spl_id": ["094a6186-10c3-ed17-e063-6394a90a601a"], "spl_set_id": ["2a723bce-a581-4558-b028-22f1f9125dd5"], "package_ndc": ["59779-534-01", "0504283455"], "is_original_packager": [true], "upc": ["0050428473290", "050428345535"], "unii": ["HDP7W44CIO"]}, "product_type": "Drugs", "event_id": "83964", "recalling_firm": "Sato Pharmaceutical Inc.", "address_1": "20695 S Western Ave Ste 240", "address_2": "N/A", "postal_code": "90501-1834", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States, Guam and Saipan", "recall_number": "D-0323-2020", "product_description": "Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 59779-534-01. UPC 050428345535", "product_quantity": "210,744 units", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20191001", "center_classification_date": "20191113", "termination_date": "20200818", "report_date": "20191120", "code_info": "Lot #: TXWP, TXTP, Exp. date Jul 2020; AXTZ, Exp. date Mar 2021; AXNP, Exp. date Jul 2021;  AXBC, Exp. date Oct 2021;  ZXWW, Exp. date Dec 2021"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0170-2015", "product_description": "Voriconazole 10 mg/mL opthalmic solution packaged in an opaque squeeze bottle eye dropper, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "40 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08012014@17, Exp 10/30/2014; 08142014@47, Exp 11/12/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Glasgow", "state": "KY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA075022", "ANDA077321"], "brand_name": ["BUSPIRONE HYDROCHLORIDE", "LISINOPRIL"], "generic_name": ["BUSPIRONE HYDROCHLORIDE", "LISINOPRIL"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"], "product_ndc": ["0615-7689", "0615-7714", "0615-7718", "0615-8252", "0615-8253", "0615-8256", "0615-8254", "0615-8255"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUSPIRONE HYDROCHLORIDE", "LISINOPRIL"], "rxcui": ["866018", "866083", "866094", "197884", "311353", "311354", "314076", "314077"], "spl_id": ["77cbe6b7-dd55-4745-a49e-1e22072beccd", "e5a3bed2-db01-4bc5-b231-ff76cecb7225"], "spl_set_id": ["72bff09c-826e-4394-a7e7-41d56ce9605b", "43fa9a16-c112-419f-8d7b-177f580462f2"], "package_ndc": ["0615-7714-39", "0615-7714-05", "0615-7714-30", "0615-7718-39", "0615-7718-31", "0615-7718-05", "0615-7718-28", "0615-7689-39", "0615-7689-31", "0615-7689-05", "0615-8252-39", "0615-8252-05", "0615-8253-39", "0615-8253-05", "0615-8253-30", "0615-8256-39", "0615-8256-05", "0615-8254-39", "0615-8254-05", "0615-8254-30", "0615-8255-39", "0615-8255-05", "0615-8255-30"], "original_packager_product_ndc": ["0093-0053", "0093-0054", "0093-1003", "68180-512", "68180-513", "68180-517", "68180-980", "68180-981"], "unii": ["207LT9J9OC", "E7199S1YWR"]}, "product_type": "Drugs", "event_id": "93336", "recalling_firm": "NCS Healthcare of Kentucky Inc", "address_1": "120 Carroll Knicely Dr", "address_2": "N/A", "postal_code": "42141-7224", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0114-2024", "product_description": "Lisinopril Tablets USP 20 mg, packaged in a) 15-count blister card (NDC 0615-7718-05), b) 30-count blister card (NDC 0615-8255-39), Rx only, Mfd By Lupin, PKG by Vangard Glasgow, KY 42141.", "product_quantity": "12 cards", "reason_for_recall": "Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots", "recall_initiation_date": "20231027", "center_classification_date": "20231121", "termination_date": "20240714", "report_date": "20231129", "code_info": "Lot#: a) 8255-3012, Exp 08/31/2024; b) 8255-3012, Exp 08/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0271-2018", "product_description": "Medline General Purpose Kit, Sterile, Single use only. Packaged in Mexico for Medline Industries, Inc., Northfield, IL 60093", "product_quantity": "700 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDA1591; Lots: 17GB5136; 17PB2138", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; ZINC SULFATE Capsule, 220 mg may be potentially mislabeled as    CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD52778_10, EXP: 5/20/2014;  CALCITRIOL, Capsule, 0.25 mcg, NDC 00054000725, Pedigree: W003638, EXP: 6/25/2014.", "address_2": "", "product_quantity": "200 Capsules", "code_info": "ZINC SULFATE, Capsule, 220 mg has the following codes    Pedigree: AD52993_34, EXP: 5/20/2014;  Pedigree: W003641, EXP: 6/25/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ZINC SULFATE Capsule, 220 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 60258013101", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-651-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0255-2018", "product_description": "Medline Vitrectomy CDS Pack, Single Use Only. Packaged in Mexico for Medline Industries, Inc., Northfield, IL 60093", "product_quantity": "5 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: CDS984258F; Lots: 177B1083", "more_code_info": ""}, {"status": "Terminated", "city": "St Petersburg", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65125", "recalling_firm": "THE COMPOUNDING SHOP, INC.", "address_1": "4000 Park St N", "address_2": "N/A", "postal_code": "33709-4034", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Florida, California, Minnesota, and Maine", "recall_number": "D-564-2013", "product_description": "B-Complex 100 mg/mL Injectable, 50 mL vials, compounded by The Compounding Shop, St. Petersburg, FL", "product_quantity": "56 vials of 50mL", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130502", "center_classification_date": "20130604", "termination_date": "20240930", "report_date": "20130612", "code_info": "All Lots"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077987"], "brand_name": ["PRAVASTATIN SODIUM"], "generic_name": ["PRAVASTATIN SODIUM"], "manufacturer_name": ["NorthStar RxLLC"], "product_ndc": ["16714-558", "16714-559", "16714-560", "16714-570"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRAVASTATIN SODIUM"], "rxcui": ["904458", "904467", "904475", "904481"], "spl_id": ["fa078b35-ee9d-4b9f-bb8d-e77949c09f88"], "spl_set_id": ["ce15ad07-3286-478f-9f30-1db6a45ed402"], "package_ndc": ["16714-558-01", "16714-558-02", "16714-559-01", "16714-559-02", "16714-560-01", "16714-560-02", "16714-570-01", "16714-570-02"], "is_original_packager": [true], "upc": ["0316714570013", "0316714559018", "0316714560014"], "unii": ["3M8608UQ61"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0350-2025", "product_description": "Pravastatin Sodium Tablets, USP, 80mg, a).90-count bottle (16714-570-01), b). 500-count bottle (NDC 16714-570-02), Rx Only, Mfd for: Northstar Rx LLC, Memphis, TN 38141, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17221770, exp. date Aug-25 17221774, exp. date Aug-25 17231251, exp. date May-26 17231262, exp. date May-26 17232112, exp. date Sep-26 17232133, exp. date Sep-26"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0208-2020", "product_description": "S-CALM INJECTION, (MAG S04/GABAPENTIN/TAURINE/THEANINE 50/50/50/50MG/ML) MDV,  10 ml glass vial, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #: S07312019DH@15, Exp 8/31/19"}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0593-2023", "product_description": "Ampicillin and Sulbactam for Injection, USP 3 grams per vial, Rx only, Mfd for Meitheal Pharmaceuticals Chicago, IL 60631, NDC 71288-006-30", "product_quantity": "1,229,090 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Ongoing", "city": "Libertyville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201991"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["A-S Medication Solutions"], "product_ndc": ["50090-1494"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975"], "spl_id": ["c83706bb-e844-4e62-b4f4-c48536ea707d"], "spl_set_id": ["0cd086d6-3ae2-476e-b93e-29055e67e8fc"], "package_ndc": ["50090-1494-3", "50090-1494-4", "50090-1494-0", "50090-1494-1", "50090-1494-2"], "original_packager_product_ndc": ["67877-159"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "96313", "recalling_firm": "A-S Medication Solutions LLC", "address_1": "2401 Commerce Dr", "address_2": "N/A", "postal_code": "60048-4464", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in U.S.", "recall_number": "D-0292-2025", "product_description": "METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG, 180 TABLETS, Packaged BY: A-S Medication Solutions, Libertyville, IL 60048 NDC 50090-1494-3.", "product_quantity": "411 180-count bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules.", "recall_initiation_date": "20250225", "center_classification_date": "20250321", "report_date": "20250402", "code_info": "Lot# 4260340; Exp.12/31/2025."}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078787"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-198", "65862-199", "65862-200"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "rxcui": ["310430", "310431", "310432"], "spl_id": ["7a45ad84-02a4-442d-8401-1a1495d084fa"], "spl_set_id": ["1a619a14-0b63-4cba-80e7-474c9a1c90b9"], "package_ndc": ["65862-198-01", "65862-198-05", "65862-198-99", "65862-198-10", "65862-198-90", "65862-198-18", "65862-198-27", "65862-199-01", "65862-199-05", "65862-199-99", "65862-199-10", "65862-199-30", "65862-199-60", "65862-199-90", "65862-199-18", "65862-199-27", "65862-200-01", "65862-200-05", "65862-200-10", "65862-200-90", "65862-200-27"], "is_original_packager": [true], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"]}, "product_type": "Drugs", "event_id": "85183", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1232-2020", "product_description": "Gabapentin Capsules, USP 100mg 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65862-198-99", "product_quantity": "26625 units", "reason_for_recall": "CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed", "recall_initiation_date": "20200318", "center_classification_date": "20200413", "termination_date": "20240325", "report_date": "20200422", "code_info": "Lot #: 198180048A, Exp. Date 04/2021; 198180061A, Exp. Date 06/2020;   19819017A1, Exp. Date 02/2021", "more_code_info": ""}, {"status": "Ongoing", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87941", "recalling_firm": "Global Sanitizers LLC", "address_1": "5979 S Valley View Blvd", "address_2": "N/A", "postal_code": "89118-3111", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product Distributed Nationwide in the USA", "recall_number": "D-0782-2021", "product_description": "MEDICALLY MINDED Hand Sanitizer Gel, ANTIMICROBIAL FORMULA, (Ethyl Alcohol 70% v/v), 8.5 FL OZ / 250 mL bottle, Made in Mexico, Distributed by SBL Brands, LLC Las Vegas, NV 89119. UPC:  6 76753 00359 1 ,", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations:  lots and products of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.", "recall_initiation_date": "20210512", "center_classification_date": "20210830", "report_date": "20210908", "code_info": "Lot No: E212020, \"Best Buy\": 5/21/2022"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "72028", "recalling_firm": "Cantrell Drug Company", "address_1": "7321 Cantrell Rd", "address_2": "N/A", "postal_code": "72207-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1157-2016", "product_description": "fentaNYL CITRATE 4 MCG/mL in 0.9% SODIUM CHLORIDE Injection, in 1 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock, AR ---  UPC: 9999993491", "product_quantity": "148 syringes", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20150821", "center_classification_date": "20160706", "termination_date": "20170203", "report_date": "20160713", "code_info": "Lot: 150370, exp 1/2/16"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "1 vial", "code_info": "Lot # t02-02-2017@102, Exp 7/26/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "QUAD MIX 50/30/1/0.2 5ML MDV (CALIF) MCG/MG/MG/MG/ML INJ, Injection, 50mcg/30mg/1mg/0.2mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0755-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Asbury Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68158", "recalling_firm": "Flawless Beauty LLC", "address_1": "1215 Main St", "address_2": "", "postal_code": "07712-5940", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1317-2014", "product_description": "Tatiomax (reduced glutathione/hydrolyzed collagen) powder for injection vials, 1200 mg/200 mg, 10-count vials per box, Manufactured by: Sujie Pharmaceutical Ltd., Tokyo, Japan, UPC 4973430081576", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling includes drug claims to act as an antidote.", "recall_initiation_date": "20140429", "center_classification_date": "20140513", "report_date": "20140521", "code_info": "Lot #: UB302, Exp 05/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77959", "recalling_firm": "Bella Pharmaceuticals, Inc.", "address_1": "3101 W Devon Ave", "address_2": "N/A", "postal_code": "60659-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within USA", "recall_number": "D-1160-2017", "product_description": "Bevacizumab Prefilled 30g and 31 gram 1.25mg/0.05mL Syringes, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.", "product_quantity": "2,334 syringes", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20170815", "center_classification_date": "20170912", "termination_date": "20180423", "report_date": "20170920", "code_info": "Lot #: 3141201, Exp. 9/13/17; 3146966, Exp . 9/20/17; 3160608, Exp. 10/5/17; 3146966, Exp.  11/1/17"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA209735"], "brand_name": ["ESOMEPRAZOLE MAGNESIUM"], "generic_name": ["ESOMEPRAZOLE MAGNESIUM"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc"], "product_ndc": ["63304-734", "63304-735"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESOMEPRAZOLE MAGNESIUM"], "rxcui": ["606726", "606730"], "spl_id": ["6d8e57e7-6cc5-4edc-8a4e-47ab7fdae397"], "spl_set_id": ["dc85d0c8-d3c4-4d37-9a5b-8f5f992bb3bf"], "package_ndc": ["63304-734-90", "63304-734-30", "63304-734-10", "63304-735-90", "63304-735-30", "63304-735-10"], "is_original_packager": [true], "upc": ["0363304734300", "0363304734904", "0363304735307"], "unii": ["R6DXU4WAY9"]}, "product_type": "Drugs", "event_id": "90891", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0004-2023", "product_description": "Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Rx Only, 90 Capsules per bottle, Manufactured by: Ohm Laboratories Inc. New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 63304-734-90.", "product_quantity": "5712 bottles", "reason_for_recall": "Superpotent Drug: Out of specification for assay at the 12-month timepoint.", "recall_initiation_date": "20220621", "center_classification_date": "20221006", "termination_date": "20230811", "report_date": "20221005", "code_info": "Lot AC14299, Exp 12/2022"}, {"status": "Terminated", "city": "Erlanger", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81606", "recalling_firm": "LGM Pharma LLC", "address_1": "2758 Circleport Dr", "address_2": "N/A", "postal_code": "41018-1079", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0296-2019", "product_description": "Thyroid Powder, USP, 25kg/drum, Rx Only, Sichuan Friendly Pharmaceutical Co., LTD. NDC: 070870-1701-1", "product_quantity": "1,307 kg", "reason_for_recall": "CGMP Deviations: Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.", "recall_initiation_date": "20180824", "center_classification_date": "20181212", "termination_date": "20230911", "report_date": "20181219", "code_info": "Lots: 161101, EXP 11/2/2016; 161201, EXP Nov 2018; 170301, EXP Feb 2019; 170501, Exp Apr 2019; 170701, Exp Jun 2019"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA018016"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0043", "0338-0049"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807551", "1807552", "1807627", "1807630", "1807631", "1807632", "1807633", "1807634", "1807639"], "spl_id": ["6ab23768-efd2-4ff1-b336-0dda08dc56e1"], "spl_set_id": ["f55bd888-5e01-474d-871b-24654c070178"], "package_ndc": ["0338-0049-01", "0338-0049-02", "0338-0049-03", "0338-0049-04", "0338-0049-10", "0338-0049-41", "0338-0049-11", "0338-0049-31", "0338-0049-48", "0338-0049-18", "0338-0049-38", "0338-0043-03", "0338-0043-04"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "71749", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1336-2015", "product_description": "0.9% Sodium Chloride Injection USP, 50 mL Single Dose VIAFLEX Container bags, Rx only, Baxter Healthcare Corporation, Deerfield, IL  60015, Product Code 2B1301, NDC 0338-0049-11.", "product_quantity": "189,120 bags", "reason_for_recall": "Presence of Particulate Matter: Customer complaint for an insect found free floating inside a single bag for each lot recalled.", "recall_initiation_date": "20150717", "center_classification_date": "20150814", "termination_date": "20161201", "report_date": "20150826", "code_info": "Lot#: P319921, Exp 12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-104-2014", "product_description": "HCG 10000u, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "180 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090368"], "brand_name": ["FLUOROURACIL"], "generic_name": ["FLUOROURACIL"], "manufacturer_name": ["Taro Pharmaceuticals U.S.A., Inc."], "product_ndc": ["51672-4118"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["FLUOROURACIL"], "rxcui": ["105583"], "spl_id": ["170232f3-4992-1e1a-e063-6394a90a38e9"], "spl_set_id": ["acca0036-f19c-459b-9dfc-9592f1cd588d"], "package_ndc": ["51672-4118-5", "51672-4118-2", "51672-4118-6"], "is_original_packager": [true], "nui": ["N0000000233", "N0000175595"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "unii": ["U3P01618RT"]}, "product_type": "Drugs", "event_id": "63685", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "N/A", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-086-2013", "product_description": "Fluorouracil Topical Cream USP, 5%, 40 g Tube, Rx only, Mfd. by: Taro Pharmaceutical Industries, Ltd. Haifa Bay, Israel 26110, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4118-6.", "product_quantity": "39,982 Tubes", "reason_for_recall": "Product Lacks Stability: Out-of-specification (OOS) results were observed for assay and description in retain samples.", "recall_initiation_date": "20121121", "center_classification_date": "20121204", "termination_date": "20170411", "report_date": "20121212", "code_info": "Lot #s: 118903, Exp. March 2013; 119477, 119483, 119743, Exp. May 2013; 119748, June 2013; 110440, Exp. September 2013; 110599, 110602, 110606, 110607, 110949, 110951, 110953, 110954, 110956, 110958, Exp. October 2013; 110962, 110963, 110965, 111659, 111844, Exp. November 2013; 111845, 111846, Exp. December 2013; 112227, 112228, Exp. January 2014."}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1419-2022", "product_description": "PEPCID COMPLETE CHEWABLE TAB BERRY 8CT SKU 903365   PEPCID AC MAXIMUM STRENGTH TABLET 25 CT SKU 902063   PEPCID AC MAXIMUM STRENGTH TABLET 8 CT SKU 914773 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 903365; 902063; 914773", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75654", "recalling_firm": "Sandoz Inc", "address_1": "100 College Rd W", "address_2": "N/A", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide throughout the USA", "recall_number": "D-0141-2017", "product_description": "L-Cysteine Hydrochloride Injection, USP, 50 mg/mL, 50 mL Pharmacy Bulk Package Vials (NDC 66758-005-01), packaged in 5 x 50 mL Vials per carton(NDC 66758-005-02), Rx only, Manufactured for: Sandoz, Inc., Princeton, NJ.", "product_quantity": "33,624 vials", "reason_for_recall": "Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised.", "recall_initiation_date": "20161109", "center_classification_date": "20161117", "termination_date": "20171017", "report_date": "20161123", "code_info": "Lot #: 2070915, 2071015, 2071415, 2071515, 2071615, 2071715, 2072115, 2072215, Exp 07/17; 2092315, 2093015, Exp 09/17; 2100115, Exp 10/17; 2120115, 2120215, Exp 12/17"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0678-2022", "product_description": "Desoximetasone Ointment USP, 0.25%, packaged in a) 100 grams tubes, NDC 52565-030-99; b) 60 grams tubes, NDC 52565-030-60; c) 15 grams tubes, NDC 52565-030-15, Rx Only, Teligent Pharma, Inc., Buena, New Jersey 08310.", "product_quantity": "13,989 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: a) 15496, Exp. 4/30/2022; 16347, Exp. 1/31/2023; b) 15496, Exp. 4/30/2022; 16298, Exp. 1/31/2023; c) 15496, Exp. 4/30/2022; 16298, Exp. 1/31/2023"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077912"], "brand_name": ["LISINOPRIL AND HYDROCHLOROTHIAZIDE"], "generic_name": ["LISINOPRIL AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-518", "68180-519", "68180-520"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "LISINOPRIL"], "rxcui": ["197885", "197886", "197887"], "spl_id": ["1474b42e-df82-41d5-9cbd-ebe3c45dcc9d"], "spl_set_id": ["515f735c-5dba-43d9-8a58-97a319cafd56"], "package_ndc": ["68180-518-02", "68180-518-01", "68180-518-30", "68180-519-30", "68180-519-01", "68180-519-02", "68180-520-02", "68180-520-30", "68180-520-01"], "is_original_packager": [true], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "E7199S1YWR"]}, "product_type": "Drugs", "event_id": "73848", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1052-2016", "product_description": "Lisinopril & Hydrochlorothiazide Tables, USP 20mg/12.5mg, packaged in a)100-count bottles and b) 5000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775 India, a) NDC 68180-519-01, b) 68180-519-30", "product_quantity": "59,520 Bottles", "reason_for_recall": "CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.", "recall_initiation_date": "20160404", "center_classification_date": "20160624", "termination_date": "20170601", "report_date": "20160706", "code_info": "Lot #: a) H303459, b) H303460, Exp 09/2016", "more_code_info": ""}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1665-2019", "product_description": "HYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b) 55 ML NDC 70731-0114-95] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: SOTALOL HCL, Tablet, 80 mg may have potentially been mislabeled as one of the following drugs:  DILTIAZEM HCL, Tablet, 120 mg, NDC 00093032101, Pedigree: AD30197_1, EXP: 5/9/2014;  PROPRANOLOL HCL ER, Capsule, 60 mg, NDC 00228277811, Pedigree: AD54605_4, EXP: 5/20/2014.", "address_2": "", "product_quantity": "202 Tablets", "code_info": "SOTALOL HCL, Tablet, 80 mg has the following codes:   Pedigree: AD30993_17, EXP: 5/9/2014;  Pedigree: AD52778_85, EXP: 5/21/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SOTALOL HCL, Tablet, 80 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093106101.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-833-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Beverly Hills", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92954", "recalling_firm": "HUMANRACE", "address_1": "9350 Civic Center Dr", "address_2": "", "postal_code": "90210-3629", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Spain, Italy, UK, and France.", "recall_number": "D-1175-2023", "product_description": "Humanrace Suncare, Ozone Face Protection Daily Moisturizer, Broad Spectrum Sunscreen SPF 30, packaged as a 53mL (1.8 fl oz.) bottle, 100% mineral, Active Ingredient: Zinc oxide 15%, Snow Mushroom, Dist. By: @Humanrace 2022 Beverly Hills, CA 90210, USA, NDC 82779-01", "product_quantity": "5046 units", "reason_for_recall": "Subpotent Drug: Product does not contain SPF that is declared on the label.", "recall_initiation_date": "20230818", "center_classification_date": "20230921", "report_date": "20230927", "code_info": "Lot #: 1732A, 1732B, 1742A, 1742B, 1742C, 1742D; Exp. 06/2024.", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1425-2022", "product_description": "QP LAXATIVE BISACODYL 5 MG TABLET 50 CT SKU 902449   QP WOMEN LAXATIVE BISCODYL TABLET 25 CT SKU 915221  distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 902449; 915221", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:   0387447", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CYCLOPENT/PHENYLEPH/TROPICAMIDE/PROPARACAINE 2%/2.5%/1%/0.5% OPHTHALMIC 5 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1492-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Yuyao", "state": "N/A", "country": "China", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83018", "recalling_firm": "NingBo Huize Commodity Co.,Ltd.", "address_1": "14 Lizhou Road", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Foreign manufacturer located in China and distributed to seven consignees located in China.", "recall_number": "D-1559-2019", "product_description": "ICEE BLUE RASPBERRY SCENTED ANTIBACTERIAL HAND GEL (Ethyl Alcohol 62%), 1.35 fl oz / 40 mL, OTC, Distributed by: JFL Enterprises, Inc. Cleveland, Ohio 44102.", "product_quantity": "13,068", "reason_for_recall": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.", "recall_initiation_date": "20190401", "center_classification_date": "20190727", "termination_date": "20230606", "report_date": "20190807", "code_info": "Lot #: 20181206, Exp 12/5/2020; 20181207, Exp 12/6/2020"}, {"status": "Ongoing", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M018"], "brand_name": ["DRY EYE RELIEF"], "generic_name": ["POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL"], "manufacturer_name": ["CARDINAL HEALTH 110, LLC. DBA LEADER"], "product_ndc": ["70000-0088"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["POLYETHYLENE GLYCOL 400", "PROPYLENE GLYCOL"], "rxcui": ["895753"], "spl_id": ["424cccfb-27a9-43c8-9793-34bc5ddcb882"], "spl_set_id": ["f8da3af5-9172-4023-be82-0fd5bd891616"], "package_ndc": ["70000-0088-1"], "is_original_packager": [true], "unii": ["B697894SGQ", "6DC9Q167V3"]}, "product_type": "Drugs", "event_id": "93346", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0135-2024", "product_description": "LEADER brand Dry Eye Relief (Polyethylene Glycol 400, 0.4% Propylene Glycol, 0.3%); 0.33 FL OZ (10 mL) dropper bottle, Sterile, Distributed By Cardinal Health, Dublin, Ohio 43017, Made in India NDC: 70000-0088-1", "product_quantity": "11,782 bottles", "reason_for_recall": "Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.", "recall_initiation_date": "20231031", "center_classification_date": "20231201", "report_date": "20231129", "code_info": "ALL LOTS", "more_code_info": ""}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78320", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-0063-2018", "product_description": "fentaNYL as citrate 2 mcg / mL, ROPIVacaine HCl 0.1%, Total Fentanyl Dose (200 mcg per 100 mL) in 0.9% Sodium Chloride single dose CADD Cassette  Rx Only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205, NDC 70004-0264-64", "product_quantity": "20 bags inside rigid translucent plastic cases (CADD)", "reason_for_recall": "Lack Of Assurance Of Sterility.", "recall_initiation_date": "20171019", "center_classification_date": "20171102", "termination_date": "20190501", "report_date": "20171108", "code_info": "Lot: 20170815@26 BUD: 11/13/2017"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0575-2017", "product_description": "TRI-BLEACHING CREAM (Retinoic Acid 0.1%, Hydroquinone 4%, Fluocinolone 0.01%), Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "44 ml", "code_info": "All lots distributed between November 2014 and May 2015;  03092015@14, 6/7/2015; 04242015@54, 7/23/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 25 mg/ml + Bupivacaine 20 mg/ml + Clonidine 2,000 mcg/ml Solution, Sterile, Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1701-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0723-2023", "product_description": "vancomycin added to 0.9% sodium chloride, 2 g/500 mL* (4 mg/mL), 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-6078-1.", "product_quantity": "7632 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-884151, 37-884153, Exp 05/03/2023; 37-885670, 37-885869, 37-885900, Exp 05/09/2023; 37-886271, Exp 05/11/2023; 37-886857, 37-886862, 37-886865, 37-886923, Exp 05/15/2023; 37-889190, 37-889191, Exp 05/23/2023; 37-889596, Exp 05/24/2023; 37-890482, 37-890487, 37-890488, Exp 05/29/2023; 37-891230, Exp 05/31/2023; 37-892589, 37-892590, Exp 06/06/2023; 37-893779, 37-893780, 37-893781, Exp 06/12/2023; 37-894665, 37-894667, Exp 06/14/2023; 37-895608, 37-895625, Exp 06/19/2023; 37-896519, Exp 06/21/2023"}, {"status": "Ongoing", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M003"], "brand_name": ["GOOD NEIGHBOR PHARMACY ALCOHOL ANTISEPTIC SKIN CLEANSER"], "generic_name": ["ISOPROPYL ALCOHOL"], "manufacturer_name": ["Amerisouce Bergen"], "product_ndc": ["46122-043"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ISOPROPYL ALCOHOL"], "rxcui": ["797544"], "spl_id": ["38529756-605f-f0c5-e063-6294a90aee23"], "spl_set_id": ["fc28cf11-afb9-4295-bee3-735ab10f6bbc"], "package_ndc": ["46122-043-78", "6122407007"], "is_original_packager": [true], "unii": ["ND2M416302"]}, "product_type": "Drugs", "event_id": "97385", "recalling_firm": "MEDLINE INDUSTRIES, LP - Northfield", "address_1": "3 Lakes Dr", "address_2": "", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0604-2025", "product_description": "Good Neighbor Pharmacy, Alcohol Prep Pads, Distributed By AmeriSource Bergen, 1 West First Avenue, Conshohocken, PA 19428, Made in China: 100 eaches per box, 30 boxes per case, (3,000 eaches per case), NDC 46122-043-78.", "product_quantity": "66,000 pads", "reason_for_recall": "Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration.", "recall_initiation_date": "20250707", "center_classification_date": "20250826", "report_date": "20250903", "code_info": "61224070074", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "65894", "recalling_firm": "Bethel Nutritional Consulting, Inc", "address_1": "599 W 190th St Ste 1", "address_2": "N/A", "postal_code": "10040-3577", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide, Puerto Rico, and internet sales", "recall_number": "D-372-2014", "product_description": "Bethel Advance (bitter orange, mulberry leaf, cassia seed extract, jobstear seed, spirulina, starch, kola nut) capsules, 400 mg, 30-count bottles, Distributed by: Bethel, Inc., Tel: (212) 568-5330, UPC 1 60126 41750 9.", "product_quantity": "13,266 bottles", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analyses detected the presence of phenolphthalein, N-di-Desmethylsibutramine, and trace amounts of sibutramine and N-Desmethylsibutramine. Sibutramine and phenolphthalein were previously available drug products but were removed from the U.S. market making these products unapproved new drugs.", "recall_initiation_date": "20130805", "center_classification_date": "20131218", "termination_date": "20180530", "report_date": "20131225", "code_info": "Lot 10092011, Exp 2014"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0471-2021", "product_description": "Ivermectin Tablets USP 3 mg 20 Tablets (2 Foil Strips of 10 tablets each) Rx Only NDC 4799-806-01 Manufactured for: Edenbridge Pharmaceuticals, LLC Parsippany, NJ 07054 877-381-3336", "product_quantity": "504 cartons", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "A1003273A"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1691-2019", "product_description": "ONDANSETRON 2 MG/ML INJECTION SOLUTION (PFV), 2 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0158-02", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0142-2019", "product_description": "Bi-Mix Injection, (Alprostadil 40 mcg/Lidocaine 2 mg/mL) Pharm D Solutions, Houston, Texas --- NDC 69699-1305-03", "product_quantity": "148 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lots: 04112018:37 Discard by: 10/1/2018; 06202018:70 Discard by: 12/16/2018; 08082018:95 Discard by: 2/4/2019"}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76982", "recalling_firm": "Jubilant Cadista Pharmaceuticals, Inc.", "address_1": "207 Kiley Dr", "address_2": "N/A", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0670-2017", "product_description": "BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, packaged in a) 60-count bottles (NDC 59746-316-60) and b) 100-count bottles (NDC 59746-316-01), Rx only, Manufactured by: Julibant Life Sciences Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD  21801, USA.", "product_quantity": "81,077 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.", "recall_initiation_date": "20160408", "center_classification_date": "20170413", "termination_date": "20170417", "report_date": "20170419", "code_info": "Lot #s: a) BU25001A, Exp 12/16; BU25002A, BU25003A, BU25004A, Exp 01/17; b) BU24003A, Exp 10/16; BU24004A, BU24005A, Exp 11/16; BU25005A, Exp 01/17", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0600-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Sciatic Nerve Formula, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955503026, NDC 57955-6030-2", "product_quantity": "14978 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 012116B Exp. 01/19; 012317E Exp. 01/20; 052516S Exp. 05/19; 071315A Exp. 07/18; 071818E Exp. 07/20; 080917B Exp. 08/19; 091416F Exp. 09/19; 120217A Exp. 12/19"}, {"status": "Terminated", "city": "Farmingdale", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090796"], "brand_name": ["IBUPROFEN"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["TIME CAP LABORATORIES, INC"], "product_ndc": ["49483-602", "49483-603", "49483-604"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["197805", "197806", "197807"], "spl_id": ["27b8b074-c62d-7214-e063-6294a90adb69"], "spl_set_id": ["ec3e8443-d742-4c25-8516-f0df4ebfccdc"], "package_ndc": ["49483-602-01", "49483-602-50", "49483-603-03", "49483-603-50", "49483-603-05", "49483-603-01", "49483-604-01", "49483-604-50", "49483-604-05", "49483-604-03"], "is_original_packager": [true], "upc": ["0349483604504", "0349483604016", "0349483602012", "0349483602500", "0349483603507", "0349483603019"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "77576", "recalling_firm": "Time-Cap Laboratories, Inc.", "address_1": "7 Michael Ave", "address_2": "N/A", "postal_code": "11735-3921", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide U.S.A.", "recall_number": "D-1055-2017", "product_description": "Ibuprofen Tablets, USP 600 mg, 500-count bottle (Capsule Shaped), Rx only, Manufactured for: Time Cap Labs, Inc., 7 Michael Avenue Farmingdale, NJ 11735, USA, Manufactured by: Marksans Pharma Ltd. Plot No. L-82, L-83 Verna Indl. Estate, Verna, Goa-403 722, India, NDC 49483-603-50", "product_quantity": "1,980 bottles", "reason_for_recall": "Presence of  foreign tablets/capsules: Ibuprofen Tablets USP, 600 mg bottles were found to contain some Ibuprofen Tablets USP 800 mg.", "recall_initiation_date": "20170616", "center_classification_date": "20170803", "termination_date": "20200529", "report_date": "20170809", "code_info": "Lot #: HN7003"}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75212", "recalling_firm": "The Apothecary Shoppe LLC", "address_1": "6136 E 51st St", "address_2": "N/A", "postal_code": "74135-7704", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Oklahoma", "recall_number": "D-0002-2017", "product_description": "Methylcobalamin 5000 mcg/mL Injection, packaged in 1, 2, 3, 4, and 5 mL vials, IM, Rx, The Apothecary Shoppe Compounding Pharmacy, Jenks, OK", "product_quantity": "419 mL total", "reason_for_recall": "Lack of Assurance of Sterility; medication was sterilized with a recalled filter", "recall_initiation_date": "20160912", "center_classification_date": "20161004", "termination_date": "20180125", "report_date": "20161012", "code_info": "071222016@24 BUD 01/08/2017, 05112016@8 BUD 11/07/2016"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0596-2017", "product_description": "HYDROCORTISONE 2.5% WITH ALOE VERA CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Ongoing", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019635"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-7800", "0264-7802"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807551", "1807552", "1807633", "1807634", "1807639"], "spl_id": ["9fa9f6b4-63b5-4632-8104-37c3dd1ee8fa"], "spl_set_id": ["7f22c06b-6b4d-4b49-a4b2-d2169f2bd653"], "package_ndc": ["0264-7800-00", "0264-7800-10", "0264-7800-20", "0264-7802-00", "0264-7802-10"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "97368", "recalling_firm": "B BRAUN MEDICAL INC", "address_1": "861 Marcon Blvd", "address_2": "N/A", "postal_code": "18109-9577", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0586-2025", "product_description": "0.9% Sodium Chloride Injection USP, L 8000, 1000mL Excel Container, Rx Only, Sterile, nonpyrogenic, single dose container, B. Braun Medical Inc., Bethlehem, PA 18018, NDC 0264-7800-00.", "product_quantity": "23,100 containers", "reason_for_recall": "Lack of Assurance of Sterility; potential for fluid leakage at one of the weld sites.", "recall_initiation_date": "20250804", "center_classification_date": "20250814", "report_date": "20250820", "code_info": "Lot #: J5C919, Exp. 08/31/2027", "more_code_info": ""}, {"status": "Terminated", "city": "McDonough", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "75537", "recalling_firm": "Love My Tru Body", "address_1": "289 Jonesboro Rd Ste 106", "address_2": "N/A", "postal_code": "30253-3725", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0223-2017", "product_description": "Skinny Bee Diet capsules, 500 mg, packaged in a 60-count bottle", "product_quantity": "74 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA: presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and phenolphthalein.", "recall_initiation_date": "20161028", "center_classification_date": "20161222", "termination_date": "20170406", "report_date": "20161228", "code_info": "Bottles stamped MFD: 03.07.2016 EXP: 03.06.2018"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA206589"], "brand_name": ["POLYMYXIN B"], "generic_name": ["POLYMYXIN B"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-234"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRATHECAL", "INTRAVENOUS", "OPHTHALMIC"], "substance_name": ["POLYMYXIN B SULFATE"], "rxcui": ["204509"], "spl_id": ["097fa44b-506b-4ee0-9f64-4b560c3ed41c"], "spl_set_id": ["a974c557-e88f-451b-a1bd-d2c656be226e"], "package_ndc": ["55150-234-10"], "is_original_packager": [true], "upc": ["0355150234103"], "unii": ["19371312D4"]}, "product_type": "Drugs", "event_id": "89457", "recalling_firm": "AuroMedics Pharma LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0556-2022", "product_description": "Polymyxin B for Injection USP, 500,000 Units per Vial, 10 mL vials, packaged in 10 vials per carton, Sterile, Rx Only, Distributed by: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-234-10", "product_quantity": "35,520 vials", "reason_for_recall": "Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot", "recall_initiation_date": "20220126", "center_classification_date": "20220210", "termination_date": "20240820", "report_date": "20220216", "code_info": "Lot CPB200013, exp 9/2022"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1149-2019", "product_description": "HCG 23 Day, 2876 Units/4.6 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "31 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"country": "United States", "city": "Dyersburg", "address_1": "450 US Hwy 51 Byp N", "reason_for_recall": "Superpotent and Subpotent drugs", "address_2": "", "product_quantity": "690 pellets", "code_info": "BUD:  10/04/2016, Lot number 04072016@40  BUD:  12/03/2016, Lot number 06162016@2  BUD:  01/07/2017, Lot number CA07112016@4", "center_classification_date": "20161108", "distribution_pattern": "U.S.", "state": "TN", "product_description": "Testosterone 200 mg/Anastrozole 9 mg Pellet, Compounded by: Wells Pharmacy Network", "report_date": "20161116", "classification": "Class II", "openfda": {}, "recalling_firm": "Wells Pharmacy Network, LLC", "recall_number": "D-0126-2017", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "75247", "termination_date": "20170329", "more_code_info": "", "recall_initiation_date": "20160919", "postal_code": "38024-3655", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Norman", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65621", "recalling_firm": "Oklahoma Respiratory Care Inc", "address_1": "623 N Porter Ave Ste 100", "address_2": "N/A", "postal_code": "73071-6000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Visit", "distribution_pattern": "Oklahoma", "recall_number": "D-818-2013", "product_description": "Oxygen, Compressed USP UN1072 Medical Gas supplied in a) 682 litres and b)165 litres cylinders, Rx only, Oklahoma Respiratory Care 800.262.9857, Norman, OK 73071", "product_quantity": "94 cylinders", "reason_for_recall": "Failed impurities/degradation specifications: Purity readings for oxygen were out of specification.", "recall_initiation_date": "20121205", "center_classification_date": "20130724", "termination_date": "20141104", "report_date": "20130731", "code_info": "Lot numbers:  03141201, 03211201, 05021201, 06271201, and 11081201.", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0660-2019", "product_description": "Dr. King's Aquaflora Kids Candida Relief  Homeopathic, 4 fl. oz. (118 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806 USA, UPC 357955332244", "product_quantity": "12127 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 011416G Exp. 12/2019; 011917R Exp. 01/2020; 041518H Exp. 09/2018; 081016E Exp. 08/2019; 092815AA Exp. 09/2018"}, {"country": "United States", "city": "Lake Mary", "address_1": "550 Technology Park Ste 1008", "reason_for_recall": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "", "product_quantity": "1 vial (15 mL)", "code_info": "ALL Lots", "center_classification_date": "20130423", "distribution_pattern": "CO, GA, MI, and Puerto Rico", "state": "FL", "product_description": "Cyclosporin in Corn Oil Injectable  Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "Axium Healthcare Pharmacy dba Balanced Solutions Compounding", "recall_number": "D-295-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64957", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20130417", "postal_code": "32746-7131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1779-2019", "product_description": "Fluorouracil 560 MG / 11.2 ML IVP  Fluorouracil 3340 MG QS 92 ML 0.9% NACL  Fluorouracil 3920 MG QS 92 ML 0.9% NACL  Fluorouracil 3760 mg QS 100 ml NS CASS  Fluorouracil 4000 MG QS 92 ml 0.9% NACL  Fluorouracil 3140 MG QS 240 ML NS PUMP  Fluorouracil 2400 MG QS 96 ML 0.9% NACL  Fluorouracil 5000 MG QS 101 ml 0.9% NACL  Fluorouracil 750 MG / 15 ML IVP  Fluorouracil 4500 mg QS 100 ml NS CASS  Fluorouracil 4100 mg QS 100 ml NS CASS  Fluorouracil 690 mg / 13.8 ml IVP  Fluorouracil 2400 MG QS 96 ML NS IV  Fluorouracil 812 MG/16.24 ML IVP  Fluorouracil 4872 MG QS 240 ML NS PUMP  Fluorouracil 4200 mg QS 100 ml NS CASS  Fluorouracil 1110 MG QS 96 ml NS IVPB  Fluorouracil 370 MG/ 50 ML NS  Fluorouracil 620 MG/ 12.4 ML SYRINGE IVP  Fluorouracil 3160 MG QS 92 ML 0.9% NACL  Fluorouracil 1050 mg QS 92 ml NS IVPB  Fluorouracil 370 MG /100 ML NS IVPB  Fluorouracil 4080 MG QS  1000 ML NS IVPB  Fluorouracil 5 MG / 0.1 ML SYRINGE  Fluorouracil 5040 MG QS 101 ml NS CADD  Fluorouracil 4224 MG QS 100 ml NS CASS  Fluorouracil 700 MG / 14 ML IVP  Fluorouracil 3550 mg QS 92 ML 0.9% NACL IV  Fluorouracil 760 MG / 15.2 ML IVP  Fluorouracil 4560 MG QS 240 ML NS PUMP  Fluorouracil 796 MG / 15.92 MLIVP  Fluorouracil 4776 MG QS 240 ML NS PUMP  Fluorouracil 930 MG QS 240 ML NS PUMP  Fluorouracil 730 MG / 14.6 ML IVP SYR  Fluorouracil 4400 MG QS 100 ml NS CADD  Fluorouracil 2430 MG QS 96 ml 0.9% NACL  Fluorouracil 4728 MG QS 100 ml NS CASS  Fluorouracil 3550 MG QS 92 ML 0.9% NACL  Fluorouracil 588 MG / 11.76 ML IVP  Fluorouracil 3528 MG QS 240 ML NS PUMP  Fluorouracil 2520 mg QS 96 ml NS IVPB  Fluorouracil 790 MG / 15.8 ml IVP  Fluorouracil 4750 mg QS 97 ml 0.9% NACL IV  Fluorouracil 2660 MG QS 96 ml NS IVPB  Fluorouracil 720 MG/ 14.4 ML IVP  Fluorouracil 4370 mg QS 92 ml 0.9% NACL IV  Fluorouracil 3280 MG QS 92 ML 0.9% NACL  Fluorouracil 780 MG / 15.6 ML IVP  Fluorouracil 4660 MG QS 97 ml 0.9% NACL  Fluorouracil 3620 MG QS 100 ml NS CASS  Fluorouracil 2370 MG QS 92 ML 0.9% NACL  Fluorouracil 800 MG / 16 ML IVP  Fluorouracil 4800 MG QS 101 ml NS CADD  Fluorouracil 4000 mg QS 92 ML 0.9% NACL IV  Fluorouracil 2480 MG QS 96 ML 0.9% NACL  Fluorouracil 688 MG / 13.76 ml IVP  Fluorouracil 4128 MG QS 1000 ML D5W IVPB  Fluorouracil 6000 MG QS 250 ml NS CASS  Fluorouracil 672 MG / 13.44 ML IVP  Fluorouracil 4032 MG / 1000 ML D5W IVPB  Fluorouracil 894 MG / 17.88 ml IVP  Fluorouracil 400 MG / 50 ML NS IVPB  Fluorouracil 840 MG / 16.8 ml IVP    Fluorouracil 590 MG/ 11.8 ML IVP", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0811-2020", "product_description": "Progesterone 200 mg Troche", "product_quantity": "1 bottle", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lot: 61242:26 Use by: 02/28/2020"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "151 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03022015@13, 5/31/2015; 03162015@51, 6/14/2015; 04072015@59, 7/6/2015; 04272015@26, 7/26/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 12.5 mg/ml Solution, Sterile-Preservative Free,The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1586-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Columbus", "address_1": "2550 John Glenn Ave Ste A", "reason_for_recall": "Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule", "address_2": "", "product_quantity": "666 cartons", "code_info": "Lot 152325, exp. 12/31/16, lot 154834, exp. 5/31/17", "center_classification_date": "20160902", "distribution_pattern": "Product was distributed in the following states: Nationwide", "state": "OH", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate (Mixed Salts of a Single-Entity Amphetamine Product) Extended-Release Capsules, CII 20 mg, 30 UD Capsules (5 x 6), Rx, Packaged and Distributed by: American Health Packaging, Columbus, OH --- Carton NDC 68084-832-25; Blister NDC 68084-832-95", "report_date": "20160914", "classification": "Class II", "openfda": {}, "recalling_firm": "Amerisource Health Services", "recall_number": "D-1488-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "75076", "termination_date": "20171218", "more_code_info": "", "recall_initiation_date": "20160824", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0321-2023", "product_description": "TPN (a) 95GM/AA, 385/DEX, 50GM/LIP 1800ML, (b)TPN AA:100GM DEX:250GM LIP:50GM 2400ML, (c) TPN: AA 80GM ; DEX 320GM ; LIP 50GM IN 2300 ml, Rx only, use with Curlin pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "24 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 25-31, 2022"}, {"status": "Terminated", "city": "San Jose", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75230", "recalling_firm": "Leiter's Compounding", "address_1": "17 Great Oaks Blvd", "address_2": "N/A", "postal_code": "95119-1359", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0013-2017", "product_description": "Cyclopentolate HCl 1% - Tropicamide 1% - PHENYLephrine HCl 2.5% in Sterile Water for Injection (Ophthalmic Solution), in a) 1 mL Total Volume (NDC 70360-017-38) and b) 10 mL Total Volume (NDC 70360-017-39) in a 15 mL Dropper Bottle, Compounded by Leiter's Compounding, San Jose, CA --- NDC 70360-017-38", "product_quantity": "76,315 total units, all products", "reason_for_recall": "Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters", "recall_initiation_date": "20160920", "center_classification_date": "20161012", "termination_date": "20170503", "report_date": "20161019", "code_info": "All unexpired lots;  a) Expirations dates of 10/03/2016 to 11/06/2016 and b) 09/25/2016 to 10/01/2016"}]